维普中文期刊产品整合服务
29篇 您的检索式:作者名="Knowlden JM"
    题名 作者 年代 出处 被引量
1Insulinlike growth factor-Ⅰ receptor signaling in tamoxifenresistant breast cancer:a supporting role to the epidermal growth factor receptor显示文摘Knowlden JM Hutcheson IR Barrow D 0,,11:1
2Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling:implication for Gefitinib (' Iressa') response and resistance显示文摘Knowlden JM Jones HE Barrow D 0,,01:1
3BRCA1 expression levels predict distant metastasis of sporadic breast cancers显示文摘Seery LT Knowlden JM Gee JM 1999Int J Cancer1999,84,5:1
4Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates ta- moxifen-resistant growth显示文摘Britton DJ Hutcheson IR Knowlden JM 2006Breast Cancer Res Treat2006,96,2:1
5c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer显示文摘Knowlden JM Gee JM Seery LT 1998Oncogene1998,17,15:1
6Nonendocrine pathways and resistance:obser- rations with antiestrongens and transduction inbihitors in combination显示文摘Nicholson RI HuTCheson IR Knowlden JM 2004Clin Cancer Res2004,10,:1
7A possible divergent role for the oestrogen receptor α and β subtypes in clinical breast cancer显示文摘 Gee JM Robertson JF 2000Int J Cancer2000,89,2:1
8Differential expression ofoestrogen regulated genes in breast cancer 显示文摘Manning DL McClelland RA Knowlden JM 1995Acta Oncol1995,34,:1
9Bidirectional cross talk between ERalpha and EGFR sagrtalling patharays regulates tamoxifen-resistant growth显示文摘Britton DJ Hutcheson IR Knowlden JM 2006Breast Cancer Res Treat2006,96,2:1
10Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signaling:Implication for gefitinib (‘Iressa') response and resistance显示文摘Knowlden JM Jones HE Barrow D 2008Breast Cancer Res Treat2008,111,1:1
11Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer:a supporting role to the epidermal growth factor receptor显示文摘Knowlden JM Hutcheson IR Barrow D 0,,:1
12Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells显示文摘 Hutcheson IR Jones HE 2003Endocrinology2003,144,3:1
13C-erbB3 and C- erbB-4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer 显示文摘Knowlden JM Gee JM Seery LT 1998Oncogene1998,17,:1
14Use of reverse transcription -polymerase chain reaction methodology to detect estrogen - regulated gene expression in small breast cancer specimens 显示文摘Knowlden JM Gee JM Bryant S 1997Clin Cancer Res1997,3,:1
15C-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer显示文摘KNOWLDEN JM GEE JM SEERY LT 1998Oncogene1998,17,:1
16Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resisitant MCF-7 cells显示文摘Knowlden JM Hutcheson IR Jones HE 2003Endocrinology2003,144,3:1
17Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens显示文摘KNOWLDEN JM GEE JM BRYANT S 1997Clin Cancer Res1997,3,:1
18Bidirec- tional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth 显示文摘Britton DJ Hutcheson IR Knowlden JM 2006Breast Cancer Res Treat2006,96,2:1
19Elevated levels of epidermal growth factor receptor/c-erbB2 het- erodimers mediate an autocrine growth regulator y path- way in tamoxifen-resistant MCF-7 cells显示文摘Knowlden JM Hutcheson IR Jones HE 2003Endocrinolo- uv2003,144,3:1
20A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer显示文摘 Gee JM Robertson JF 2000Int J Cancer2000,89,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费